The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective prevalence estimation of BRCA1, BRCA2, and other germline mutations associated with hereditary pancreatic cancer (HPC) using a comprehensive gene panel in an unselected cohort of Mexican patients with pancreatic ductal adenocarcinoma (PDAC).
 
Vanessa Rosas Camargo
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb (Mexico); Roche
 
Jazmin Arteaga
No Relationships to Disclose
 
Javier Melchor Ruan
No Relationships to Disclose
 
Salvador Escorza
No Relationships to Disclose
 
Alberto Cedro-Tanda
No Relationships to Disclose
 
Silvia Vidal
No Relationships to Disclose
 
Lucero Itzel Torres Valdiviezo
No Relationships to Disclose
 
Miriam Heidi Cisneros Cordero
No Relationships to Disclose
 
Cesar Arce Sandoval
No Relationships to Disclose
 
Mónica Isabel Meneses Medina
Honoraria - MSD
Consulting or Advisory Role - Bristol-Myers Squibb (Mexico); MSD Oncology
Speakers' Bureau - Ipsen; MSD Oncology; Roche
Research Funding - AstraZeneca (I)
Travel, Accommodations, Expenses - Amgen; Ipsen
 
Marytere Herrera
No Relationships to Disclose
 
Fidel David David Huitzil Melendez
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca; Roche